First-pass extracted concept

CRISPR/Cas9 off-target detection methods

Candidate: concept label1 source documents3 linked claims

Jump to evidence Jump to sources Jump to claims

Live refresh every 5sNext refresh in 5s

Evidence Snippets

We discuss in silico, in vitro, and in vivo detection methods, highlighting their strengths and limitations.

Evidence 1Source 1DOI PubMedprovenance

Supporting Sources

Source 1primary paper2025MEDDOI PubMed

1 evidence snippet 3 linked claims Claim 1 Claim 2 Claim 3

Linked Claims

Claim 1limitation statementsupports2025Source 1DOI PubMed

Accurately assessing unintended genomic modifications in vivo and ensuring long-term safety in clinical applications remain unresolved challenges.

Claim 2problem statementsupports2025Source 1DOI PubMed

Off-target effects remain a significant challenge for CRISPR-based genome editing because they can lead to unintended mutations and genomic instability.

Claim 3review scopesupports2025Source 1DOI PubMed

The source reviews in silico, in vitro, and in vivo methods for detecting CRISPR off-target effects and discusses their strengths and limitations.